Latest statistics and disclosures from Yu Fan's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABGI, AVIR, AGLE, DFFN, and represent 100.00% of Yu Fan's stock portfolio.
- Reduced shares in these 2 stocks: LUNG (-$14M), AVIR.
- Sold out of its positions in LUNG.
- Yu Fan was a net seller of stock by $-17M.
- Yu Fan has $8.8M in assets under management (AUM), dropping by -76.90%.
- Central Index Key (CIK): 0001668029
Tip: Access up to 7 years of quarterly data
Positions held by Yu Fan consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for Yu Fan
Companies in the Yu Fan portfolio as of the June 2021 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Abg Acquisition Corp I Cl A Shs (ABGI)||55.5||$4.9M||501k||9.80|
|Atea Pharmaceuticals (AVIR)||34.9||$3.1M||-52%||144k||21.48|
|Aeglea Biotherapeutics (AGLE)||8.8||$780k||112k||6.96|
|Diffusion Pharmaceuticals In Com Par (DFFN)||0.7||$66k||90k||0.73|
Past Filings by Yu Fan
SEC 13F filings are viewable for Yu Fan going back to 2020